Bio Rad Laboratories Inc/ US0905722072 /
| 18/11/2024 22:10:00 | Chg. -7.16 | Volume | Bid12:28:07 | Ask12:28:07 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 313.15USD | -2.24% | 311,967 Turnover: 52.41 mill. |
125.26Bid Size: 200 | 497.90Ask Size: 100 | 7.18 bill.USD | - | - |
Assets
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 488.6140 | 493.4960 | 508.6900 | 499.3390 | 491.3710 | ||||||
| Intangible Assets | 161.6090 | 174.1130 | 133.1230 | 145.5000 | 199.5000 | ||||||
| Long-Term Investments | 830.7900 | 1,027.7360 | 2,655.7090 | 4,638.2050 | 9,561.1400 | ||||||
| Fixed Assets | 2,005.9800 | 2,296.3510 | 3,587.6220 | 5,828.7450 | 10,832.7650 | ||||||
| Inventories | 524.9610 | 594.8040 | 583.8150 | 554.0070 | 622.2530 | ||||||
| Accounts Receivable | 372.3480 | 464.8470 | 392.4430 | 392.6720 | 419.4240 | ||||||
| Cash and Cash Equivalents | 456.2640 | 383.8240 | 431.5260 | 660.6720 | 662.2050 | ||||||
| Current Assets | 1,844.5240 | 1,976.6490 | 2,023.4780 | 2,180.1550 | 2,139.8350 | ||||||
| Total Assets | 3,850.5040 | 4,273 | 5,611.1000 | 8,008.9000 | 12,972.6000 | ||||||
Liabilities
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 133.1090 | 135.1820 | 122.4500 | 107.0140 | 139.4510 | ||||||
| Long-term debt | 434.1860 | 434.6000 | 438.9000 | 13.6000 | 12.3000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 222.9000 | 222.2000 | 553.2000 | 997.8000 | - | ||||||
| Liabilities | 1,263.7450 | 1,342.7500 | 1,590.7690 | 2,253.8430 | 3,092.6600 | ||||||
| Share Capital | .0020 | .0020 | .0020 | .0020 | .0020 | ||||||
| Total Equity | 2,586.7590 | 2,930.2500 | 4,020.3310 | 5,755.0570 | 9,879.9400 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 3,850.5040 | 4,273 | 5,611.1000 | 8,008.9000 | 12,972.6000 | ||||||
Income Statement
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,068.1720 | 2,160.2000 | 2,289.4150 | 2,311.6590 | 2,545.6260 | ||||||
| Depreciation (total) | - | - | 138.1000 | 134.2000 | - | ||||||
| Operating Result | 53.1940 | 116.6500 | -103.3410 | 229.6610 | 410.9570 | ||||||
| Interest Income | 21.9420 | 21.9140 | -23.9620 | -23.4160 | -21.8610 | ||||||
| Income Before Taxes | 41.5600 | 97.8000 | 512.7000 | 2,261.1000 | 4,907.6000 | ||||||
| Income Taxes | -13.4350 | 24.4000 | -147 | -502.4000 | -1,101.4000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 28.1250 | 122.2000 | 365.6000 | 1,758.7000 | 3,806.2670 | ||||||
Per Share
Cash Flow
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 216.4330 | 103.9000 | 285.5000 | 457.9000 | 575.3000 | ||||||
| Cash Flow from Investing Activities | -213.8800 | -175.5720 | -186.9780 | -208.8890 | -60.2500 | ||||||
| Cash Flow from Financing | 9.0200 | .3410 | -48.6800 | -22.7580 | -523.0410 | ||||||
| Decrease / Increase in Cash | -1.2850 | -72.4400 | 49.1810 | 228.4870 | 4.4640 | ||||||
| Employees | 8,250 | 8,150 | 8,260 | 8,120 | - | ||||||
